Regional Monitoring EECA
by ECUO PLWH
Showing 1-20 of 20 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of LithuaniaInsurance FundViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab25.90233030777.071777.072016YesYesNot specified
2Russian FederationGovernmentGlaxoSmithKlineTivicayDolutegravir (as sodium salt)50mg tab7.531278030225.942696233.42016YesYesNot specified
3Republic of BelarusGlobal FundViiV HealthcareDolutegravir (as sodium salt)50mg tab5.433330003016310016300IDA Foundation20152015-12-072016-04-19Not specifiedNot specifiedNot specified
4UkraineGovernmentViiV HealthcareDolutegravir (as sodium salt)50mg tab6.83572478030205.07826169387.812015Not specifiedNot specifiedNot specified
5Republic of PolandGovernmentGlaxoSmithKlineTivicayDolutegravir (as sodium salt)50mg tab15.986716800030479.656002685760Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
6Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.5318003052510605565002015Not specifiedNot specifiedNot specified
7Republic of PolandGovernmentGlaxoSmithKlineTivicayDolutegravir (as sodium salt)50mg tab15.9137500030477.3925001193475Krajowe Centrum ds. AIDS2016YesYesNot specified
8Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab0.017760000300.53200010602015Not specifiedNot specifiedNot specified
9GeorgiaGlobal FundAurobindo Pharma Ltd.DolutegravirDolutegravir (as sodium salt)50mg tab0.122318630303.676212279.07partnership for supply. chain management (PFSCM)2016YesYesYes
10UkraineGovernmentAurobindo Pharma Ltd.DolutegravirDolutegravir (as sodium salt)50mg tab0.190324780305.718264716.462016YesYesYes
11Republic of LithuaniaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab24.6693030740.071740.072015Not specifiedNot specifiedNot specified
12Republic of BelarusGlobal FundGlaxo Operations UK LimitedTivicayDolutegravir (as sodium salt)50mg tab6.3493615030190.4820539048.4UNDP/UNICEF2016YesNoYes
13Republic of LatviaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab23.33835631030700.1518771314181.5National Health Service (NHC)2016Not specifiedNot specifiedNot specified
14Republic of BelarusGlobal FundViiV HealthcareDolutegravir (as sodium salt)50mg tab5.433330003016310016300IDA Foundation20152015-12-072016-05-28Not specifiedNot specifiedNot specified
15Republic of LatviaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab20.72633030621.791621.792015Not specifiedNot specifiedNot specified
16Republic of PolandGovernmentGlaxoSmithKlineTivicayDolutegravir (as sodium salt)50mg tab15.91312300030477.3941001957299Krajowe Centrum ds. AIDS2016YesYesNot specified
17Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.5570003052519009975002015Not specifiedNot specifiedNot specified
18GeorgiaGlobal FundAurobindo Pharma Ltd.Dolutegravir (as sodium salt)50mg tab0.122310170303.673391244.13partnership for supply. chain management (PFSCM)2016YesYesNot specified
19UkrainePEPFARAurobindo Pharma Ltd.DolutegravirDolutegravir (as sodium salt)50mg tab0.166734090203051136345681702016YesYesYes
20Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.515000305255002625002015Not specifiedNot specifiedNot specified